Know Cancer

forgot password

Text Reminders to Immunize in a Managed Care Organization

11 Years
18 Years
Not Enrolling
Human Papilloma Virus

Thank you

Trial Information

Text Reminders to Immunize in a Managed Care Organization

The study setting is western New York State and the Southern Tier of New York State (15
counties total). Investigators will work with the Monroe Plan for Medical Care, an
IPA-model managed care organization (MCO) that serves Medicaid managed care and SCHIP
enrollees. The MCO will conduct regular reviews of insurance claims data and the New York
State Immunization Information System of adolescents ages 11-<18 years. Parents (all over
18 years of age) of adolescents will receive the texted messages on their phones.

There are no enrollment restrictions based upon race or ethnic origin. The inclusion
criteria are that the adolescents are a) enrolled in Medicaid or SCHIP through the Monroe
Plan, b) have been enrolled greater than 6 months with the Monroe Plan (in order to have
sufficient claims data to determine whether they are due for a well child care visit or
recommended immunizations), c) the Monroe Plan has received their consent to send preventive
care text messages, d) their child attend a primary care practice that has agreed to
participate and d) they are between the ages of 11-<18 years at the start of the study.

The key independent measure is group allocation (intervention vs. control); an
intention-to-treat strategy will be used to assess the effectiveness of text messaging
reminders. Key outcome measures will be: 1) receipt of 0, 1, 2 or 3 doses of HPV vaccine 2)
interval (in days) between doses and 3) having a preventive visit in the 6 month period.

Inclusion Criteria:

- 11-<18 years

- Member of MCO for >6 months

- Opted in to receive texted reminders from MCO

Exclusion Criteria:

Type of Study:


Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research

Outcome Measure:

HPV vaccination (dose 1)

Outcome Time Frame:

6 months

Safety Issue:


Principal Investigator

Cynthia M Rand, MD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Rochester


United States: Institutional Review Board

Study ID:




Start Date:

March 2013

Completion Date:

October 2013

Related Keywords:

  • Human Papilloma Virus
  • HPV vaccination
  • Adolescent well care
  • Adolescent HPV immunization
  • HPV
  • Papilloma



University of RochesterRochester, New York  14642